Colorectal Cancer Canada

What Colorectal Cancer Canada does

Colorectal Cancer Canada (CCC) is a Canadian non-profit charitable organization founded in 1998 and headquartered in Westmount, Quebec, that operates as the country's national colorectal cancer patient advocacy body. The organization delivers colorectal cancer awareness, patient and caregiver education, peer support, and policy advocacy, serving patients in treatment, survivors, family members, and caregivers across Canada with bilingual (English/French) resources. Its core service portfolio includes educational content covering diagnosis, treatment options (surgery, chemotherapy, radiation, targeted therapy, immunotherapy), biomarkers, clinical trials, genetic testing, and Lynch syndrome; the monthly Tush Talks webinar series hosted by Associate Director of Communications Carl Bindman; the CRC Drug Search directory; and large-scale awareness events including the 30-year Push for Your Tush 5K/10K walk/run across 12-13 Canadian cities and the Giant Colon Tour.

The organization does not develop proprietary technology products. Its primary assets are its brand reputation (over 25 years as Canada's leading CRC patient organization), its national bilingual distribution footprint, and its ecosystem of partnerships with Q-CROC (Quebec's clinical research network covering 98% of provincial recruiting trials), Fondation Québécois du Cancer, academic institutions including McMaster University and The Ottawa Hospital, and Onco-Innovations Limited, alongside a diversified roster of approximately 30 pharmaceutical and healthcare corporate sponsors.

CCC's business model is donation- and sponsorship-funded. Revenue is generated through individual donations, fundraising events (Push for Your Tush, Kick-Ass Golf Tournament), and corporate partnerships and sponsorships with pharma and healthcare companies including Merck, Novartis, Pfizer, Roche, Taiho, Thermo Fisher Scientific, AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, GSK, Astellas, Natera, Incyte, Johnson & Johnson, Takeda, Eisai, BeiGene, Guardant Health, Regeneron, Coloplast, CircleBack, Illumina, ConvaTec, Sandoz, Kohler, Hollister, and TD Bank. The organization is led by President and CEO Barry Stein (also Data Privacy Officer), operates with 1-10 employees, and does not publicly disclose financial results. Its primary strategic advocacy initiative is the Screen at 45 campaign, which seeks to lower Canada's colorectal cancer screening age from 50 to 45.

Name

Colorectal Cancer Canada

Legal name

Colorectal Cancer Canada

Website

https://colorectalcancercanada.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Colorectal Cancer Canada is a Canadian non-profit founded in 1998 that delivers colorectal cancer awareness, patient and caregiver education, peer support, and policy advocacy across Canada through bilingual resources, fundraising events, and the Screen at 45 screening-age campaign.

Ownership category

akta.pro rank

Product category

Cancer Patient Advocacy Services

NAICS

Voluntary Health Organizations (813212), Health Care and Social Assistance (62)

SIC

Services-Health Services (8000)

akta.pro primary industry

Gastrointestinal Oncology (HLAKAFAK)

akta.pro secondary industry

Colorectal Disease & Proctology (HLAKAEAJ)

Keywords

• Colorectal cancer awareness
• Patient advocacy services
• Cancer support groups
• Cancer screening education
• Patient education resources

Headquarters

HQ city

Westmount

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Donations and Fundraising: The organization raises funds through individual donations, fundraising events (Kick-Ass Golf Tournament, Push for Your Tush walk/run), and general fundraising campaigns. Revenue supports awareness programs, patient support, and advocacy initiatives.
2. Corporate Partnerships and Sponsorships: Colorectal Cancer Canada receives support from pharmaceutical companies and healthcare corporations including Merck, Novartis, Pfizer, Roche, Taiho, Thermo Fisher Scientific, AbbVie, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, GSK, Astellas, Natera, Incyte, Johnson & Johnson, Takeda, Eisai, BeiGene, Guardant Health, Regeneron, Coloplast, CircleBack, Illumina, ConvaTec, Sandoz, Kohler, Hollister, and TD Bank. These sponsorships support organizational operations and programs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Colorectal Cancer Canada is a non-profit patient advocacy organization that provides colorectal cancer awareness, education, patient and caregiver support, and policy advocacy. Its core activities include educational resources about diagnosis and treatment, support groups, the CRC Drug Search tool, the Push for Your Tush walk/run fundraising events, the Giant Colon Tour educational exhibit, monthly Tush Talks webinars, and the national Screen at 45 campaign to lower the screening age.

Product overview

Colorectal Cancer Canada is a non-profit patient advocacy organization that provides colorectal cancer awareness, education, patient/caregiver support, and advocacy services. The organization does not offer a commercial product, software platform, or technology solution. Its service portfolio includes educational resources, support programs, screening advocacy campaigns (such as Screen At 45), patient stories, webinars (Tush Talks), CRC Drug Search tool, and various awareness events. The organization publishes research updates and clinical trial information as part of its educational mission.

Differentiator

Problem solved

Functional benefit

Products and services

• Push for Your Tush 5K/10K Walk/Run National 5K/10K walk/run fundraising event held in 12-13 Canadian cities with a virtual participation option, intended for patients, caregivers, supporters, and the general public to raise awareness and funds for colorectal cancer.
• Giant Colon Tour Touring educational event featuring a large inflatable colon exhibit used to educate the public about colorectal cancer symptoms, anatomy, and the importance of screening.
• Tush Talks Webinar Series Monthly virtual webinar series hosted by Colorectal Cancer Canada featuring medical professionals (oncologists, social workers, fertility specialists) who discuss colorectal cancer topics for patients, caregivers, and the public.
• Screen at 45 Campaign National policy advocacy campaign urging Canadian health authorities to lower the colorectal cancer screening age from 50 to 45, including research, media outreach, and public education.
• CRC Drug Search Online searchable tool on the Colorectal Cancer Canada website that helps patients and caregivers find information about colorectal cancer drug treatments.
• Kick-Ass Golf Tournament Annual fundraising golf tournament held at Angus Glen Golf Course that supports colorectal cancer awareness and patient programs.
• Patient and Caregiver Support Programs Support programs including support groups, peer connections, counseling resources, and the Family Toolbox for caregivers, available free to patients and family members affected by colorectal cancer.

Quantifiable outcome

• Screening at 45 could prevent over 12,000 colorectal cancer cases and save more than 5,000 lives in Canada

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Q-CROC (Quebec Clinical Research Organization in Cancer)coreStrategic or Co-development Partner · 1 January 2008Since 2008, Q-CROC coordinates a network of 16 of the most active oncology clinical research healthcare facilities in Quebec, representing over 98% of recruiting clinical trial studies in the province. The network includes more than 275 researchers and 500 research professionals. Q-CROC and CCC created a practice community for physicians specializing in colorectal cancer to optimize patient participation in clinical trials.
• Fondation Québécois du Cancer (FQC)coreStrategic or Co-development PartnerFor over 40 years, FQC has been a major provider of support, help, and comfort for all people affected by cancer in Quebec. Their mission is to offer practical and moral support to those affected by cancer throughout Quebec through services that reflect their needs. The partnership includes mutual client referrals and joint physical activity initiatives.
• Onco-Innovations LimitedminorStrategic or Co-development PartnerOnco-Innovations Limited announced hosting a virtual Precision Oncology Forum in December 2025, chaired by Colorectal Cancer Canada. The roundtable brought together senior leaders from industry, government, and academia to develop roadmaps for implementing next-generation cancer treatments and advancing precision oncology data infrastructures.
• McMaster UniversityminorStrategic or Co-development PartnerAcademic partnership through Tush Talks webinar featuring Munaza Jamil from McMaster University discussing increasing equitable access to clinical trials.
• The Ottawa HospitalminorStrategic or Co-development PartnerAcademic partnership through Tush Talks featuring Dr. Rebecca Auer, surgical oncologist and researcher at The Ottawa Hospital, discussing immunotherapy and its benefits for colorectal cancer patients.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• American Cancer Society: Largest US cancer nonprofit with nationwide screening, research, and patient support programs. Broad incumbent in the same advocacy and screening-awareness space, though at much greater scale and broader cancer scope.
• Canadian Cancer Society: Canada's largest national cancer charity with broad funding of research, prevention, and patient support across all cancer types. CCC competes with CCS for donor dollars and policy attention despite its narrower CRC focus.
• Cancer Research UK: Largest cancer research and awareness funder in the UK with screening advocacy and patient information programs. Comparable in scope and disease-specific advocacy model, though much larger and research-heavy.

Direct peers

• Crohn's and Colitis Canada: Canadian nonprofit focused on inflammatory bowel disease, which overlaps significantly with colorectal cancer risk and patient populations. Peer in GI-disease awareness, fundraising model, and bilingual national programming.
• Fight Colorectal Cancer: US-based colorectal cancer advocacy organization focused on policy, research, and patient empowerment. Direct peer in mission and advocacy model (especially policy work such as lowering screening age), though US-based.
• Canadian Digestive Health Foundation: Canadian nonprofit focused on digestive health education, screening, and research — directly adjacent to colorectal cancer in GI disease scope. Comparable in awareness and education model.
• Colorectal Cancer Alliance: The largest US-based colorectal cancer nonprofit focused on screening, patient support, and research funding. Most directly comparable peer — same disease focus, similar patient advocacy and awareness programming, but operating in the US with a larger budget.
• Fondation Québécois du Cancer: Quebec-based cancer support organization and direct CCC partner providing patient services and physical activity programs. Peer in patient-support mission and Quebec operating footprint.
• Lung Cancer Canada: Canadian cancer-specific nonprofit focused on a single cancer type with similar advocacy, patient support, and policy mission structure. Peer in operating model, funding approach, and Canadian nonprofit landscape.

Emerging players

• Lynch Syndrome Canada: Canadian patient organization focused on Lynch syndrome, a hereditary condition that significantly elevates colorectal cancer risk. Overlaps with CCC's high-risk genetic sub-segment and screening advocacy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PLk10ShGWszTArhYJ0zB_iKH2vZ9fHJgcW
• Instagraminstagram.com/coloncanada
• Xx.com/coloncanada
• Facebookfacebook.com/coloncanada
• LinkedInlinkedin.com/company/coloncanada

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Colorectal Cancer Canada